Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saud H AlDubayan

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
American Journal of Human Genetics|May 5, 2022
Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genesRiaz Gillani, Sabrina Y Camp, Seunghun Han, et al.
JAMA|November 17, 2020
Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and MelanomaSaud H AlDubayan, Jake R Conway, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Analysis of evolutionary dynamics and clonal architecture in prostate cancerJake R Conway, Alok K Tewari, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Science (New York, N.Y.)|January 2, 2025
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Cancer Immunology Research|June 21, 2019
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal CancerCarino Gurjao, David Liu, Matan Hofree, et al.
Nature Cancer|February 5, 2022
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncologyBrendan Reardon, Nathanael D Moore, Nicholas S Moore, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinomaAmin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Nature Communications|May 13, 2025
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, et al.
Cell Reports|September 8, 2021
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerAlok K Tewari, Alexander T M Cheung, Jett Crowdis, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Human Genetics|May 5, 2022
Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genesRiaz Gillani, Sabrina Y Camp, Seunghun Han, et al.
JAMA|November 17, 2020
Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and MelanomaSaud H AlDubayan, Jake R Conway, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Analysis of evolutionary dynamics and clonal architecture in prostate cancerJake R Conway, Alok K Tewari, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Science (New York, N.Y.)|January 2, 2025
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Cancer Immunology Research|June 21, 2019
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal CancerCarino Gurjao, David Liu, Matan Hofree, et al.
Nature Cancer|February 5, 2022
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncologyBrendan Reardon, Nathanael D Moore, Nicholas S Moore, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinomaAmin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Nature Communications|May 13, 2025
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, et al.
Cell Reports|September 8, 2021
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerAlok K Tewari, Alexander T M Cheung, Jett Crowdis, et al.
Pageof 4